Evidence map›Paper›PMID 32393973›Full record

ReviewInflammatory bowel diseases2020

Management of Acute Severe Ulcerative Colitis in a Pregnant Woman With COVID-19 Infection: A Case Report and Review of the Literature.

Melissa H Rosen, Jordan Axelrad, David Hudesman, David T Rubin, Shannon Chang

Open access · bronzeAbstract readCase ReportsReview
In one paragraph

Review in Inflammatory bowel diseases, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 7 pooled it
3.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 7 syntheses or guidelines pooled it, 45 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. COVID-19 in patients with inflammatory bowel disease: A systematic review of clinical data.Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver · 2020
    Pooled it
  4. Systematic Review on Inflammatory Bowel Disease Patients With Coronavirus Disease 2019: It Is Time to Take Stock.Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association · 2020
    Pooled it
  5. Clinical characteristics, prognostic factors, and maternal and neonatal outcomes of SARS-CoV-2 infection among hospitalized pregnant women: A systematic review.International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics · 2020
    Pooled it
  6. Pooled it
  7. Pooled it
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Impact of COVID-19 on Patients with Inflammatory Bowel Disease.Journal of exploratory research in pharmacology · 2022
    Article
  14. Article
  15. Gastrointestinal manifestations in COVID-19.Transactions of the Royal Society of Tropical Medicine and Hygiene · 2021
    Review
  16. Article
  17. Review
  18. Review
  19. Article
  20. Human Coronavirus Infections and Pregnancy.Maternal-fetal medicine (Wolters Kluwer Health, Inc.) · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Melissa H RosenDivision of Gastroenterology and Hepatology, NYU Langone Health, New York, NY.
Jordan AxelradDivision of Gastroenterology and Hepatology, NYU Langone Health, New York, NY.
David HudesmanDivision of Gastroenterology and Hepatology, NYU Langone Health, New York, NY.
David T RubinUniversity of Chicago Medicine Inflammatory Bowel Disease Center, Chicago, IL.
Shannon ChangDivision of Gastroenterology and Hepatology, NYU Langone Health, New York, NY.
NYU Langone Health · USUniversity of Chicago · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

First detected in Wuhan, China, the novel 2019 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an enveloped RNA beta-coronavirus responsible for an unprecedented, worldwide pandemic caused by COVID-19. Optimal management of immunosuppression in inflammatory bowel disease (IBD) patients with COVID-19 infection currently is based on expert opinion, given the novelty of the infection and the corresponding lack of high-level evidence in patients with immune-mediated conditions. There are limited data regarding IBD patients with COVID-19 and no data regarding early pregnancy in the era of COVID-19. This article describes a patient with acute severe ulcerative colitis (UC) during her first trimester of pregnancy who also has COVID-19. The case presentation is followed by a review of the literature to date on COVID-19 in regard to inflammatory bowel disease and pregnancy, respectively.

Indexed as

Abortion, SpontaneousColitis, UlcerativeCoronavirus InfectionsPandemicsPneumonia, ViralPregnancy ComplicationsAdultAntiviral AgentsBetacoronavirusClinical Laboratory TechniquesCOVID-19COVID-19 TestingC-Reactive ProteinCyclosporineFemaleHumansAntiviral AgentsC-Reactive ProteinCyclosporineImmunosuppressive AgentsMethylprednisolonecoronavirusCOVID-19cyclosporineinflammatory bowel diseasepregnancyulcerative colitis

Identifiers

PMID32393973
PMCPMC7239163
OpenAlexW3025301240

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.